Acadia Healthcare Company, Inc. ACHC

FY2025 · ended Dec 31, 2025 · Revenue $3.31B, +5.0% YoY · Filed Feb 27, 2026

Acadia Healthcare Company, Inc. (ACHC) files with the SEC under industry code 8093, Services-Specialty Outpatient Facilities, NEC. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $3.3 billion and a net loss of $1.1 billion. Free cash flow was -$439.9 million. As of Sep 30, 2026 it held $163.3 million in cash and investments and $2.5 billion in total debt.

Revenue (TTM)
$3.41B
+4.5% vs year-ago TTM
Net income (TTM)
$-1.13B
-1150.7% vs year-ago TTM
Operating cash flow (TTM)
$235.19M
-29.8% vs year-ago TTM
Free cash flow (TTM)
$-23.86M
+93.1% vs year-ago TTM
EPS (TTM)
$-12.42
-1157.1% vs year-ago TTM
Dividend per share
None
Shares outstanding
92.21M
-0.8% vs prior year
Net cash
$-2.34B
as of Sep 30, 2026
Operating margin
29.2%
FY 2019

Company profile

Industry
Services-Specialty Outpatient Facilities, NEC (SIC 8093)
Listed as
ACHC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Franklin, TN
SEC filer status
Large accelerated filer
SEC CIK
1520697

Other Services-Specialty Outpatient Facilities, NEC companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$3.3B
$3.2B
$2.9B
$2.6B
$2.3B
Net income
-$1.1B
$255.6M
-$21.7M
$273.1M
$190.6M
Diluted EPS
-$12.16
$2.78
-$0.24
$2.98
$2.10
Operating cash flow
$131.9M
$129.7M
$462.3M
$380.6M
$374.5M
Free cash flow
-$439.9M
-$560.7M
$38.2M
$84.4M
$129.7M
Total assets
$5.5B
$6.0B
$5.4B
$5.0B
$4.8B
Total liabilities
$3.4B
$2.8B
$2.5B
$2.1B
$2.2B
Stockholders' equity
$1.9B
$3.1B
$2.8B
$2.8B
$2.5B
Cash and investments
$133.2M
$76.3M
$100.1M
$97.6M
$133.8M
Total debt
$2.7B
$2.1B
$1.5B
$1.5B
$1.6B

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2026 Nov 4, 2026
8-K Current report
Other events
Sep 25, 2026 Sep 25, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jul 28, 2026 Jul 28, 2026
10-Q Quarterly report Jul 28, 2026 Jun 30, 2026
8-K Current report
Other events
May 18, 2026 May 18, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.